Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| K23DK133677-01A1 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | NIH |
Not provided
Not provided
Not provided
Not provided
The purpose of this mixed methods study is to adapt CAPABLE as CAPABLE Transplant to accomplish two things: 1) To resolve barriers to being classified as active on the Kidney Transplant (KT) waitlist, 2) as a surgical prehabilitation intervention targeting the pre-frail/ frail KT waitlist population. It consists of two phases- an open label pilot and a randomized waitlist control trial, and 3) pilot test the feasibility and acceptability for CAPABLE Transplant in symptom and waitlist specific metrics amongst low-income active kidney transplant waitlist candidates.
CAPABLE is a multicomponent goal-directed program that reduces physical disability by working with the person and environment but has not been explored in prehabilitation research. The purpose of this study is to adapt CAPABLE, an existing evidence-based program for functionally and socio-economically vulnerable older adults, as a prehabilitation intervention for people with frailty awaiting KT.
As in CAPABLE, the delivery characteristics of CAPABLE Kidney Transplant consist of an assessment-driven, individually tailored package of interventions delivered over the course of 4 months by an occupational therapist (OT) (~6 home visits for ≤ 1hour), a registered nurse (RN) (~4 home visits for ≤ 1hour) and a handy worker (HW).
In earlier phases, research team members conducted preliminary activities to design the CAPABLE Kidney Transplant intervention using Human-Centered Design techniques.
This study will seek to accomplish two aims:
The investigators will collect feedback during the open label pilot to further refine the intervention that will be tested as part of the randomized control trial.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Open Label Pilot | Experimental | The Open Label Pilot will include testing the CAPABLE Transplant intervention with 3 individuals on the waitlist. |
|
| Randomized Control Pilot- Intervention Arm | Experimental | After the open label pilot, 20 participants will be randomized to the CAPABLE Transplant intervention. They will be assessed at baseline, after the 4 month intervention, and after the waitlist control arm. |
|
| Randomized Control Pilot- Waitlist Control Arm | Active Comparator | The waitlist control group, 20 participants, will receive the intervention after they have served as controls to the immediate treatment group, ensuring all participants have access to the intervention. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| CAPABLE Transplant- Open Label Pilot | Behavioral | As in CAPABLE, the delivery characteristics of CAPABLE Transplant consist of an assessment-driven, individually tailored package of interventions delivered over the course of 4 months by an occupational therapist (OT) (~6 home visits for ≤ 1hour), a registered nurse (RN) (~4 home visits for ≤ 1hour) and a handy worker (HW). Adaptations targeting those currently KT inactive will be made on a per-client basis as part of the open-label pilot. We will further refine and develop the intervention by receiving feedback from the open label pilot participants and CAPABLE clinicians who implemented the pilot to gain their perspective of the acceptability and feasibility of implementing the CAPABLE-Transplant intervention. Based on this feedback, the study team will have developed an adapted iteration of the prototype. |
| Measure | Description | Time Frame |
|---|---|---|
| Waitlist-status as assessed by data obtained by the National Kidney Registry | Death (any cause), Time Inactive Change of waitlist status (inactive to active, delisting) | 0, 16 weeks, 32 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Change in self-efficacy as assessed by the Coping Self-Efficacy Instrument | Coping Self-Efficacy is a 13 item instrument on a scale of 0 ('can't do at all') to 10 ('certain can do'). A higher score indicates higher level of self-efficacy when implementing coping strategies. Score range 0-130. | Baseline, 16 weeks, 32 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Acceptability at endpoint of intervention assessed by survey | Score on Likert scale-based questions re: program content & structure satisfaction, willingness to recommend. Survey developed by study team. | 16 weeks |
| Feasibility as assessed by qualitative questions |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Melissa Hladek, PhD | Contact | 4106142418 | mhladek1@jh.edu | |
| Meagan Clemence, BA | Contact | 808-636-0737 | mcleme26@jh.edu |
| Name | Affiliation | Role |
|---|---|---|
| Melissa Hladek, PhD | Johns Hopkins School of Nursing | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Johns Hopkins School of Nursing | Recruiting | Baltimore | Maryland | 21205 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003863 | Depression |
| D007676 | Kidney Failure, Chronic |
| ID | Term |
|---|---|
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
| D051436 | Renal Insufficiency, Chronic |
| D051437 | Renal Insufficiency |
Not provided
Not provided
Waitlist Control Trial
Not provided
Not provided
The assessment collector will be blinded as to whether a participant is in the intervention or waitlist group
|
| CAPABLE Transplant- Randomized Control Trial | Behavioral | As in CAPABLE, the delivery characteristics of CAPABLE Transplant consist of an assessment-driven, individually tailored package of interventions delivered over the course of 4 months by an occupational therapist (OT) (~6 home visits for ≤ 1hour), a registered nurse (RN) (~4 home visits for ≤ 1hour) and a handy worker (HW). Refinements based on the open label pilot results will be included. |
|
| Change in self-efficacy as assessed by the Self-Efficacy of Chronic Disease Management Instrument |
Self-Efficacy of Chronic Disease Management Instrument is a 6 item instrument on a visual analog scale, ranging from 1 (not at all confident) to 10 (totally confident). Lower scores indicate lower self-efficacy as indicated by confidence. Score range 6-60. |
| Baseline, 16 weeks, 32 weeks |
| Change in Pain as assessed by the Brief Pain Inventory | The Brief Pain Inventory - is a 4-item self-administered questionnaire used to evaluate the severity of a patient's pain and the impact of this pain on the patient's daily functioning. The patient is asked to rate their worst, least, average, and current pain intensity, list current treatments and their perceived effectiveness, and rate the degree that pain interferes with general activity, mood, walking ability, normal work, relations with other persons, sleep, and enjoyment of life on a 10 point scale. For the 10 point scale, 0 indicated no pain and 10 indicates the worst imaginable pain. Score range 0-40. | Baseline, 16 weeks, 32 weeks |
| Change in Depression as assessed by the Patient Health Questionnaire Depression Scale (PHQ-8) | The PHQ-8 contains 8 questions, with a 0-3 scale. A score of 10 or greater is considered major depression, 20 or more is severe major depression. Score range 0-30. | Baseline, 16 weeks, 32 weeks |
| Change in Social engagement as assessed by the Lubben Social Network Scale | The Lubben Social Network Scale is a 7-item questionnaire that measures the size of social networks of family and friends. The score ranges between 0 and 30, with higher scores indicated more social engagement. | Baseline, 16 weeks, 32 weeks |
| Change in Social engagement as assessed by the Krause-Borawski-Clark Support Interactions Scale | The Krause-Borawski-Clark Support Interactions Scale is a 10-item self-reported questionnaire that measures social interactions. The scale is broken down into different domains; scores range from very often (4); fairly often (3); once in a while (2); never (1) or binary-- satisfied (1) or not satisfied (0) depending on domain within the questionnaire. Items are summed to form a single composite score range 10-40, Higher scores on the scale is associated with better personal perception and social support. | Baseline, 16 weeks, 32 weeks |
| Change in Fatigue/Quality of Life as assessed by the Kidney disease Quality of Life Scale | The Kidney disease Quality of Life Short Form is a 20-item self-report outcome measure for patients on dialysis. Higher scores indicate better health-related quality of life. Scores range from 0-100. | Baseline, 16 weeks, 32 weeks |
| Change in Frailty as assessed by the Fried Frailty Phenotype | The Fried Frailty Phenotype contains 5 criteria: unintentional weight loss >10lbs >5% of body mass in the last year, weakness (handgrip strength measurement), exhaustion (based on the Center for Epidemiological Studies Depression Scale), slow gait (walking time over a distance), and low physical activity. People who had none of the criteria were considered non-frail, people who had 1 and 2 criteria were considered pre-frail, and people who had ≥3 criteria were considered frail. | Baseline, 16 weeks, 32 weeks |
| Change in Health Team Communication as assessed by the CollaboRATE Scale Measure | The CollaboRATE scale measure is a 3 item self-report questionnaire on patient's shared decision making. It is scored on a 10-point anchored scale, ranging from 0 ("no effort was made") to 9 ("every effort was made"). Higher scores indicate more shared decision making. | Baseline, 16 weeks, 32 weeks |
| Change in Function as assessed by Lawton & Brody's assessment of Instrumental Activities of Daily Living Scale | The assessment contains 8 questions with answers that are either a score of 0 or 1. A summary score ranges from 0 (low function, dependent) to 8 (high function, independent) for women, and 0 through 5 for men to avoid potential gender bias. | Baseline, 16 weeks, 32 weeks |
| Change in Function as assessed by the Katz Index of Independence in Activities of Daily Living | 6 questions, each 1 point for a total score of 6. A score closer to 6 indicates high patient independence. | Baseline, 16 weeks, 32 weeks |
Open/ Close Ended Questions, Recruitment Rate, Completion Rate, Data Collection Rate, Mean time for survey administration, Withdrawal Rate, Cost. Questions developed by study team. |
| 16 weeks |
| Fidelity as assessed by percent completion of intervention items | % tasks/ patient- directed content delivery per session for Nurse & Occupational Therapist, % completion of home modifications | 16 weeks |
| D007674 |
| Kidney Diseases |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D002908 | Chronic Disease |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |